Identification of Potential RBPJ-Specific Inhibitors for Blocking Notch Signaling in Breast Cancer Using a Drug Repurposing Strategy.

Rui, Mengjie; Cai, Min; Zhou, Yu; Zhang, Wen; Gao, Lianglai; Mi, Ke; Ji, Wei; Wang, Dan; Feng, Chunlai

Rui, Mengjie; Cai, Min; Zhou, Yu; Zhang, Wen; Gao, Lianglai; Mi, Ke; Ji, Wei; Wang, Dan; Feng, Chunlai.

Afiliación

Rui M; Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
Cai M; Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
Zhou Y; Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
Zhang W; Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
Gao L; Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
Mi K; Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
Ji W; Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
Wang D; Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
Feng C; Department of Pharmaceutics, School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.

Pharmaceuticals (Basel) ; 15(5)2022 Apr 29.

Article en En | MEDLINE | ID: mdl-35631382

Palabras clave

Notch signaling; RBPJ protein; acarbose; breast cancer; drug repurposing; fidaxomicin; schaftoside

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Pharmaceuticals (Basel) Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google